Ken Griffin Codexis, Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$2.65 - $3.92 $795 - $1,176	300 Added 3.95%	7,900 $24,000
Q1 2024 May 15, 2024	BUY	$2.59 - $4.65 $9,065 - $16,275	3,500 Added 85.37%	7,600 $26,000
Q4 2023 Feb 14, 2024	BUY	$1.54 - $3.37 $4,004 - $8,762	2,600 Added 173.33%	4,100 $12,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.75 $49,650 - $124,125	-33,100 Reduced 95.66%	1,500 $2,000
Q2 2023 Aug 14, 2023	BUY	$2.21 - $4.43 $3,315 - $6,645	1,500 Added 4.53%	34,600 $96,000
Q1 2023 May 15, 2023	BUY	$3.81 - $6.76 $113,538 - $201,448	29,800 Added 903.03%	33,100 $137,000
Q4 2022 Feb 14, 2023	BUY	$4.26 - $6.84 $14,058 - $22,572	3,300 New	3,300 $15,000

126

48.2M

33.7K

20.2K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $204M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.